Cell
Volume 171, Issue 4, 2 November 2017, Pages 934-949.e16
ArticleTumor and Microenvironment Evolution during Immunotherapy with Nivolumab
Under an Elsevier user license
open archive
Graphical Abstract
Keywords
melanoma
tumor microenvironment
tumor immune evasion
immunotherapy
nivolumab
ipilimumab
tumor mutation load/tumor mutation burden
neoantigen load
clonal evolution/clonal selection
T cell receptor repertoire
Cited by (0)
© 2017 Elsevier Inc.